Analytical Biological Services
Private Company
Total funding raised: $2.9M
Overview
ABS Bio is a long-established, privately-held contract research service provider supporting the global biopharmaceutical industry. Its core business model revolves around offering essential research services—including human biospecimen supply, cell culture, biostorage, and custom assay development—which are critical for preclinical and diagnostic research. The company has recently signaled growth through strategic acquisition (Cureline, Inc.) and leadership renewal, positioning itself as a integrated partner in the drug discovery supply chain. Backed by multiple quality accreditations, ABS Bio leverages over 30 years of experience to provide reliable, scalable support to its clients.
Technology Platform
Integrated service platform for human biospecimen procurement, biostorage, cell culture, and custom biological reagent production, supported by CAP/ISO quality systems.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
ABS Bio competes in the fragmented contract research services market against large global CROs (e.g., LabCorp, Charles River), specialty biospecimen providers, and regional labs. Differentiation is based on niche expertise, quality certifications, client service, and the integrated suite of offerings post-Cureline acquisition.